-
ETTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Entasis Therapeutics (ETTX)
Company Profile
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 33.55 mm | 33.55 mm | 33.55 mm | 33.55 mm | 33.55 mm | 33.55 mm |
Cash burn (monthly) | (no burn) | 949.17 k | 5.31 mm | 4.63 mm | 4.58 mm | 3.89 mm |
Cash used (since last report) | n/a | 33.28 mm | 186.16 mm | 162.37 mm | 160.72 mm | 136.23 mm |
Cash remaining | n/a | 266.27 k | -152.61 mm | -128.82 mm | -127.17 mm | -102.68 mm |
Runway (months of cash) | n/a | 0.3 | -28.7 | -27.8 | -27.7 | -26.4 |
13F holders | Current |
---|---|
Total holders | 29 |
Opened positions | 10 |
Closed positions | 5 |
Increased positions | 7 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 141.47 mm |
Total shares | 64.39 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
INVA Innoviva | 57.35 mm | $125.01 mm |
Clarus Lifesciences III | 1.34 mm | $3.91 mm |
Gardner Lewis Asset Management L P | 1.25 mm | $2.75 mm |
Beryl Capital Management | 1.13 mm | $2.49 mm |
TPG GP A | 1.02 mm | $2.25 mm |
Vanguard | 502.62 k | $1.11 mm |
Susquehanna International | 393.56 k | $866.00 k |
Renaissance Technologies | 350.35 k | $771.00 k |
Geode Capital Management | 180.83 k | $397.00 k |
Deltec Asset Management | 155.61 k | $342.00 k |